教育背景及工作经历：
2022-08 至 今, 山西医科大学, 转化医学研究中心, 讲师
2019-09 至 2022-07, 北京协和医学院, 微生物与生化药学, 博士
2016-09 至 2019-07, 北京协和医学院, 药学, 硕士
2012-09 至 2016-07, 哈尔滨医科大学, 药学, 学士

(1) 国家自然科学基金委员会, 面上项目, 81973366, 基于MITF途径双重下调免疫检查点FGL1和PD-L1的土贝母苷甲类新化合物TBM-19抗肿瘤免疫作用及机制研究, 2020-01-01至2023-12-31, 55万元, 在研, 参与
(2) 国家自然科学基金委员会, 面上项目, 81974494, 基于免疫哨卡PD-L1苦豆碱衍生物肿瘤免疫治疗的化学基础与直接靶标探，2020-01-01至2023-12-31, 56万元, 在研, 参与

（1）Wei Wei#; Qingxuan Zeng#; Yan Wang#; Xixi Guo; Tianyun Fan; Yinghong Li; Hongbin Deng; Liping Zhao; Xintong Zhang; Yonghua Liu; Yulong Shi; Jingyang Zhu; Xican Ma; Yanxiang Wang*; Jiandong Jiang*; Danqing Song*; Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects, Acta Pharmaceutica Sinica B, 2022 (中科院1区，IF: 14.907)
（2）Qingxuan Zeng#; Wei Wei#; Tianyun Fan; Hongbin Deng; Xixi Guo; Liping Zhao; Xintong Zhang; Sheng Tang; Jiandong Jiang; Yinghong Li; Yanxiang Wang*; Danqing Song*; Capture and Identification of Dual Specificity Mitogen-Activated Protein Kinase Kinase 7 as a Direct Proteomic Target of Berberine to Affect the c-JunN-Terminal Kinase Pathway, CCS Chemistry, 2021, 4: 1534-1544  (中国化学会旗舰新刊)
（3）Qingxuan Zeng#; Kun Wang#; Xin Zhang; Yulong Shi; Yueying Dou; Zhihao Guo; Xintong Zhang; Na Zhang; Hongbin Deng; Yinghong Li*; Danqing Song*; Structure–activity relationship and biological evaluation of 12N-substituted aloperine derivatives as PD-L1 down-regulatory agents through proteasome pathway, Bioorganic Chemistry, 2021, 117: 105432 (中科院1区，IF: 5.307)
（4）Qingxuan Zeng#; Hongbin Deng#; Yinghong Li#; Tianyun Fan; Yang Liu; Sheng Tang; Wei Wei; Xiaojia Liu; Xixi Guo; Jiandong Jiang; Yanxiang Wang*; Danqing Song*; Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity, Journal of Medicinal Chemistry, 2020, 64(1): 768-781 (中科院1区，IF: 8.039)
（5）Qingxuan Zeng#; Huiqiang Wang#; Wei Wei; Tingting Guo; Lian Yu; Yanxiang Wang; Yuhuan Li*; Danqing Song*; Synthesis and biological evaluation of berberine derivatives as a new class of broad-spectrum antiviral agents against Coxsackievirus B, Bioorganic Chemistry, 2020, 95: 103490-103490 (中科院1区，IF: 5.307)

(1) 邓洪斌；刘晓嘉；冯艳春；张娜;宋丹青；殷明晓；董靖雯；曾庆轩；抗肿瘤药物和用途, 2021-0427, 中国, CN202010750818.0
(2) 宋丹青；蒋建东；孔维佳；范田运；程阳阳；汪燕翔；曾庆轩；魏伟；李迎红；郭茜茜；赵丽萍；巴马汀衍生物、其制备方法和抗血栓用途, 2021-11-12, 中国, CN202111339954.1